commercial-phases_LBB_phase-0_foundation_color_800x800
Phase 0

Foundation

We build the strategic and brand infrastructure your innovation needs to compete. Before there's clinical data or a cleared device, there's a story investors, partners, and early stakeholders have to believe.

Phase Overview

Foundation is the starting point of the commercialization journey, where a biomedical innovator establishes the strategic, brand, and investor infrastructure needed to compete. At this stage the company is typically pre-clinical or in early development, focused on protecting IP, validating the business model, and building the assets that will support fundraising, clinical partnerships, and eventual market entry. Whether you're a first-time founder or an experienced team, the quality of the strategic foundation built here shapes every commercial decision that follows.


What Happens in This Phase

Each phase draws on a different combination of our disciplines and sub-disciplines. These are the ones that establish the strategic and brand infrastructure your innovation will build on.

Market Research & Competitive Analysis

The market, the competition, and the unmet need assessed to ground every strategic decision that follows in evidence rather than assumption.

Corporate Brand Strategy

The key tenets of your organization defined to inform operational, visual, textual, positioning, and go-to-market decisions.

Product Brand Strategy

Guideposts established for the device itself, enabling differentiation, communication, education, and commercialization as it develops.

Investor Strategy

A narrative built to communicate with clarity, build investor confidence, and support your fundraising objectives.

Name Development

Strategically aligned, memorable names created for your organization, device, or platform.

Brand Design

A brand identity crafted to signal clinical precision, innovation, credibility, and market readiness from the first impression.

Investor Pitch Decks

Visually compelling, data-informed presentations that instill confidence and support funding goals.

Regulatory Compliant Messaging

Early messaging developed to build awareness and establish credibility without creating claims problems later.

_BK25156_1 Color (800 x 800)
What You Walk Away With

The strategic and brand infrastructure to compete: market research and competitive analysis, defined corporate and product brand strategy, an investor narrative and pitch materials, a developed name where needed, a complete brand identity, and regulatory-compliant messaging that builds early credibility with the stakeholders who matter most.

Why This Phase Matters

Capital, talent, and clinical partners all commit to a company long before they can evaluate a device. What they evaluate instead is the clarity of the story and the credibility of the organization telling it. A foundation built deliberately makes every subsequent raise, partnership, and hire easier. One assembled as needed leaves you rebuilding it under pressure, usually at the moment it matters most.

commercial-phases_LBB_phase-1_clinical-evidence_color_800x800
NEXT PHASE

Clinical Evidence

With the strategic foundation in place, your program moves into Clinical Evidence, where first human data becomes scientific credibility and stakeholder conviction.

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your brand up to the task? We help you turn Just Might into Just Mighty.